Divis Laboratories Sees 13.01% Surge in Open Interest to 49,717 Contracts
Divis Laboratories Ltd has seen a notable rise in open interest, reaching 49,717 contracts, alongside a trading volume of 102,456 contracts. The stock has outperformed its sector, achieving a total return of 6.26% over two days, while also demonstrating strong liquidity and delivery volume.
Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 49,717 contracts, reflecting a rise of 5,723 contracts or 13.01% from the previous open interest of 43,994. This uptick in open interest coincides with a trading volume of 102,456 contracts, indicating heightened activity in the stock.In terms of price performance, Divis Laboratories has outperformed its sector by 1.71%, marking a consecutive gain over the last two days with a total return of 6.26% during this period. The stock reached an intraday high of Rs 6,267.5, representing a 2.67% increase. Notably, the stock is currently trading above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average.
Additionally, the delivery volume on October 7 was recorded at 561,000 shares, which is an impressive 82.18% increase compared to the 5-day average delivery volume. With a market capitalization of Rs 1,62,918 crore, Divis Laboratories continues to demonstrate robust liquidity, supporting trade sizes of up to Rs 6.92 crore. Overall, the notable rise in open interest and trading activity underscores the stock's dynamic position in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
